AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25125488 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 23289935 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based social skills training (SST) using the 12 weeks manualised SOSTA-FRA program
Number of subjects: 220
Study 23289935 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 220
Study 21431374 — intervention group
Group type: EXPERIMENTAL
Intervention: Measured gap resection technique (Group A)
Number of subjects: 30
Study 21431374 — intervention group
Group type: COMPARATOR
Intervention: Gap balancing technique (Group B)
Number of subjects: 30
Study 18496322 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mug of ipratropium bromide
Number of subjects: 68
Study 18496322 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study 15504429 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggressive behavior monitoring using the overt aggression scale (OAS)
Number of subjects: 157
Study 15504429 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychopathology assessment using the positive and negative syndrome scale (PANSS)
Number of subjects: 157
Study 15504429 — intervention group
Group type: EXPERIMENTAL
Intervention: Total PANSS scores
Number of subjects: 157
Study 15504429 — intervention group
Group type: EXPERIMENTAL
Intervention: PANSS positive subscale scores
Number of subjects: 157
Study 12707120 — intervention group
Group type: EXPERIMENTAL
Intervention: CPB group
Number of subjects: 71
Study 12707120 — intervention group
Group type: COMPARATOR
Intervention: OPCAB group
Number of subjects: 71
Study 12707120 — intervention group
Group type: EXPERIMENTAL
Intervention: CPB-DA group
Number of subjects: 71
Study 12707120 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 71
Study 10561649 — intervention group
Group type: EXPERIMENTAL
Intervention: Successful external cephalic version
Number of subjects: 30
Study 10561649 — intervention group
Group type: COMPARATOR
Intervention: Failed external cephalic version
Number of subjects: 30
Study 8764356 — intervention group
Group type: EXPERIMENTAL
Intervention: Niravoline (2 mg dose, single 30-min i.v. infusion)
Number of subjects: 12
Study 8764356 — intervention group
Group type: EXPERIMENTAL
Intervention: Niravoline
Number of subjects: 12
Study 8764356 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 2063855 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (rHuEPO; 150 U/kg)
Number of subjects: 117
Study 2063855 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (rHuEPO; 100 U/kg)
Number of subjects: 117
Study 2063855 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (rHuEPO; 50 U/kg)
Number of subjects: 117
Study 2063855 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 117
Study 2063855 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (rHuEPO)
Number of subjects: 117
Study 6355216 — intervention group
Group type: EXPERIMENTAL
Intervention: D-penicillamine
Number of subjects: 24
Study 6355216 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 24
Study 30497695 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral carbohydrate loading (400 mL, 2 hours before surgery)
Number of subjects: 120
Study 30497695 — intervention group
Group type: COMPARATOR
Intervention: Fasting (8 hours prior to surgery)
Number of subjects: 120
Study 30290803 — intervention group
Group type: EXPERIMENTAL
Intervention: Hysteroscopic septum resection
Number of subjects: 68
Study 30290803 — intervention group
Group type: COMPARATOR
Intervention: Expectant management
Number of subjects: 68
Study 28299267 — intervention group
Group type: COMPARATOR
Intervention: Micromotor
Number of subjects: 30
Study 28299267 — intervention group
Group type: EXPERIMENTAL
Intervention: Piezosurgery
Number of subjects: 30
Study 28299267 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study 24998880 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone furoate/vilanterol (FF/VI) 100/25 mcg once-daily
Number of subjects: 931
Study 24998880 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone propionate/salmeterol (FP/SAL) 250/50 mcg twice-daily
Number of subjects: 931
Study 22730955 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialectical Behavior Therapy (DBT)
Number of subjects: 63
Study 22730955 — intervention group
Group type: COMPARATOR
Intervention: Optimized treatment-as-usual (O-TAU)
Number of subjects: 63
Study 20436354 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (CVD risk reduction)
Number of subjects: 388
Study 20436354 — intervention group
Group type: EXPERIMENTAL
Intervention: Rural group who decreased CVD risk
Number of subjects: 388
Study 20436354 — intervention group
Group type: EXPERIMENTAL
Intervention: Urban group who decreased CVD risk
Number of subjects: 388
Study 17556623 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenteral aminosidine sulphate (AS) 14 mg/kg/d for 21 days
Number of subjects: 38
Study 17556623 — intervention group
Group type: COMPARATOR
Intervention: Intravenous meglumine antimonate (MA) 20 mg/kg/d for 28 days
Number of subjects: 38
Study 12939546 — intervention group
Group type: EXPERIMENTAL
Intervention: Rate control combined with antithrombotic therapy
Number of subjects: 2600
Study 12939546 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhythm control combined with antithrombotic therapy
Number of subjects: 2600
Study 12939546 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of life scores
Number of subjects: 2600
Study 12939546 — intervention group
Group type: EXPERIMENTAL
Intervention: Efficacy and safety of drugs used in treating AF
Number of subjects: 2600
Study 10730228 — intervention group
Group type: EXPERIMENTAL
Intervention: 36 Gy radiation treatment
Number of subjects: 95
Study 10730228 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 Gy radiation treatment
Number of subjects: 95
Study 10730228 — intervention group
Group type: COMPARATOR
Intervention: Control group (no radiation treatment)
Number of subjects: 95
Study 8931411 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alfa therapy (10 million U three times a week for 16 weeks)
Number of subjects: 47
Study 8931411 — intervention group
Group type: COMPARATOR
Intervention: Control group (10 normal subjects)
Number of subjects: 47
Study 1372126 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 Gy
Number of subjects: 270
Study 1372126 — intervention group
Group type: COMPARATOR
Intervention: 4 Gy
Number of subjects: 270
Study 2860942 — intervention group
Group type: EXPERIMENTAL
Intervention: sulphapyridine
Number of subjects: 0
Study 2860942 — intervention group
Group type: EXPERIMENTAL
Intervention: 5‐aminosalicylic acid
Number of subjects: 0
Study 2860942 — intervention group
Group type: COMPARATOR
Intervention: sulphasalazine
Number of subjects: 0
Study 29583081 — intervention group
Group type: EXPERIMENTAL
Intervention: Icosapent ethyl 4 g/day
Number of subjects: 146
Study 29583081 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 146
Study 27005016 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 kVp
Number of subjects: 80
Study 24606612 — intervention group
Group type: EXPERIMENTAL
Intervention: Institutional delivery
Number of subjects: 60601
Study 24606612 — intervention group
Group type: EXPERIMENTAL
Intervention: Home birth with skilled birth attendant (SBA)
Number of subjects: 60601
Study 24606612 — intervention group
Group type: COMPARATOR
Intervention: Home birth without skilled birth attendant (SBA)
Number of subjects: 60601
Study 21506018 — intervention group
Group type: EXPERIMENTAL
Intervention: MBSR(BC)
Number of subjects: 0
Study 21506018 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 0
Study 21568143 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic variceal ligation (EVL)
Number of subjects: 150
Study 21568143 — intervention group
Group type: COMPARATOR
Intervention: Cyanoacrylate injection
Number of subjects: 150
Study 19298038 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound navigation
Number of subjects: 60
Study 19298038 — intervention group
Group type: COMPARATOR
Intervention: Manual pointer palpation
Number of subjects: 60
Study 16023513 — intervention group
Group type: EXPERIMENTAL
Intervention: Plain soap with handwashing promotion
Number of subjects: 606
Study 16023513 — intervention group
Group type: COMPARATOR
Intervention: Plain soap
Number of subjects: 606
Study 12449403 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsatile cold compression (PCC) device applied to the ankle
Number of subjects: 24
Study 12449403 — intervention group
Group type: COMPARATOR
Intervention: Posterior molded splint
Number of subjects: 24
Study 10355414 — intervention group
Group type: EXPERIMENTAL
Intervention: Off-pump coronary operation
Number of subjects: 22
Study 7856782 — intervention group
Group type: EXPERIMENTAL
Intervention: Special Intervention group with a 12-session, 12-week smoking cessation program using nicotine gum
Number of subjects: 3923
Study 2071783 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 months of immunotherapy (IT) at 2 micrograms of Amb a I
Number of subjects: 79
Study 2071783 — intervention group
Group type: EXPERIMENTAL
Intervention: 22 months of immunotherapy (IT) at 24 micrograms of Amb a I
Number of subjects: 79
Study 2071783 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 year of immunotherapy (IT) at 2 micrograms of Amb a I
Number of subjects: 79
Study 2071783 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 years of immunotherapy (IT) at 2 micrograms of Amb a I
Number of subjects: 79
Study 2071783 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 years of immunotherapy (IT) at 24 micrograms of Amb a I
Number of subjects: 79
Study 2071783 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 79
Study 6129719 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (40 to 320 mg per day for 6 to 31 months)
Number of subjects: 16
Study 6129719 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 31117880 — intervention group
Group type: EXPERIMENTAL
Intervention: Navigation-assisted TKR
Number of subjects: 50
Study 31117880 — intervention group
Group type: COMPARATOR
Intervention: Conventional jig-based TKR
Number of subjects: 50
Study 28416097 — intervention group
Group type: EXPERIMENTAL
Intervention: Presurgical nasoalveolar molding (PNAM)
Number of subjects: 0
Study 28416097 — intervention group
Group type: COMPARATOR
Intervention: Control group (no PNAM)
Number of subjects: 0
Study 26467901 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous infusion of autologous, unfractionated bone marrow
Number of subjects: 80
Study 26467901 — intervention group
Group type: COMPARATOR
Intervention: Placebo intervention: infusion of autologous blood
Number of subjects: 80
Study 23385110 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheelchair Skills Training Program (WSTP) - two 1-hour training sessions
Number of subjects: 20
Study 23385110 — intervention group
Group type: COMPARATOR
Intervention: Control group - single socialization contact
Number of subjects: 20
Study 20628897 — intervention group
Group type: EXPERIMENTAL
Intervention: Forced sex with one partner
Number of subjects: 522
Study 20628897 — intervention group
Group type: EXPERIMENTAL
Intervention: Forced sex with 2+ partners
Number of subjects: 522
Study 20628897 — intervention group
Group type: EXPERIMENTAL
Intervention: High number of partners with strong tendency to drink alcohol before sex
Number of subjects: 522
Study 20628897 — intervention group
Group type: EXPERIMENTAL
Intervention: Unprotected sex with a nonspousal partner and > 20 days of alcohol consumption in the last 30 days
Number of subjects: 522
Study 20628897 — intervention group
Group type: EXPERIMENTAL
Intervention: Discussion about family violence with larger social networks
Number of subjects: 522
Study 20041782 — intervention group
Group type: EXPERIMENTAL
Intervention: Yeast hydrolysate (YH) administered for 2 weeks
Number of subjects: 0
Study 18605225 — intervention group
Group type: EXPERIMENTAL
Intervention: COLD-fX (immune-modulator)
Number of subjects: 0
Study 18605225 — intervention group
Group type: EXPERIMENTAL
Intervention: REMEMBER-fX (neuro-modulator)
Number of subjects: 0
Study 15234398 — intervention group
Group type: EXPERIMENTAL
Intervention: HDB tirofiban (25 microg/kg/3 min, and infusion of 0.15 microg/kg/min for 24 to 48 h)
Number of subjects: 202
Study 15234398 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 202
Study 15234398 — intervention group
Group type: EXPERIMENTAL
Intervention: HDB tirofiban
Number of subjects: 202
Study 11163738 — intervention group
Group type: EXPERIMENTAL
Intervention: Trandolapril
Number of subjects: 119
Study 11163738 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 119
Study 9052467 — intervention group
Group type: EXPERIMENTAL
Intervention: Transurethral microwave thermotherapy (TUMT)
Number of subjects: 60
Study 9052467 — intervention group
Group type: COMPARATOR
Intervention: Transurethral resection of the prostate (TURP)
Number of subjects: 60
Study 8378292 — intervention group
Group type: EXPERIMENTAL
Intervention: DA Salbutamol/DNCG (0.1 mg Salbutamol and 1.0 mg DNCG/puff)
Number of subjects: 20
Study 8378292 — intervention group
Group type: COMPARATOR
Intervention: DA Salbutamol alone (0.1 mg Salbutamol puff)
Number of subjects: 20
Study 3527070 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose metoclopramide and droperidol (regimen I)
Number of subjects: 24
Study 3527070 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of high-dose metoclopramide, droperidol and methylprednisolone (regimen II)
Number of subjects: 24
Study 3527070 — intervention group
Group type: EXPERIMENTAL
Intervention: Regimen II
Number of subjects: 24
Study 31470006 — intervention group
Group type: EXPERIMENTAL
Intervention: Small-intestinal-release peppermint oil (182 mg)
Number of subjects: 190
Study 31470006 — intervention group
Group type: EXPERIMENTAL
Intervention: Ileocolonic-release peppermint oil (182 mg)
Number of subjects: 190
Study 31470006 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 190
Study 31470006 — intervention group
Group type: EXPERIMENTAL
Intervention: Both peppermint oil groups
Number of subjects: 190
Study 30129316 — intervention group
Group type: EXPERIMENTAL
Intervention: Ludloff osteotomy assisted with a 3D printed navigation template
Number of subjects: 28
Study 30129316 — intervention group
Group type: COMPARATOR
Intervention: Traditional Ludloff osteotomy
Number of subjects: 28
Study 26929955 — intervention group
Group type: COMPARATOR
Intervention: Conventional method (Ni-Cr)
Number of subjects: 50
Study 26929955 — intervention group
Group type: EXPERIMENTAL
Intervention: CAD/CAM system (iTero/industrial milling)
Number of subjects: 50
Study 26929955 — intervention group
Group type: EXPERIMENTAL
Intervention: CAD/CAM system (3S/industrial milling)
Number of subjects: 50
Study 26929955 — intervention group
Group type: EXPERIMENTAL
Intervention: CAD/CAM system (Cerec Bluecam/industrial milling)
Number of subjects: 50
Study 26929955 — intervention group
Group type: EXPERIMENTAL
Intervention: CAD/CAM system (Cerec BlueCam/Sirona milling)
Number of subjects: 50
Study 24879304 — intervention group
Group type: EXPERIMENTAL
Intervention: Switched to consuming Orbs
Number of subjects: 4
Study 24879304 — intervention group
Group type: EXPERIMENTAL
Intervention: Tobacco abstinent
Number of subjects: 4
Study 24879304 — intervention group
Group type: COMPARATOR
Intervention: Continued smoking
Number of subjects: 4
Study 24879304 — intervention group
Group type: COMPARATOR
Intervention: Dual use of cigarettes and Orbs
Number of subjects: 4
Study 21207506 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback activated (using a tilt sensor on the trunk)
Number of subjects: 20
Study 21207506 — intervention group
Group type: COMPARATOR
Intervention: Biofeedback inactivated
Number of subjects: 20
Study 20516031 — intervention group
Group type: EXPERIMENTAL
Intervention: DMARD monotherapy
Number of subjects: 9052
Study 20516031 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapies
Number of subjects: 9052
Study 18982929 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg simvastatin per day
Number of subjects: 0
Study 18982929 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 16092581 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained-release bupropion, 300 mg/d
Number of subjects: 784
Study 16092581 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 784
Study 12585148 — intervention group
Group type: EXPERIMENTAL
Intervention: Danxiaoling Pill (DXLP)
Number of subjects: 58
Study 12585148 — intervention group
Group type: COMPARATOR
Intervention: Composite Yiganling (Control)
Number of subjects: 58
Study 11869855 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary estrogen administration
Number of subjects: 50
Study 11869855 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischemic preconditioning
Number of subjects: 50
Study 11869855 — intervention group
Group type: COMPARATOR
Intervention: Glibenclamide (glyburide)
Number of subjects: 50
Study 10731736 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 143
Study 10731736 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 143
Study 7924241 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Therapy (GT)
Number of subjects: 113
Study 7924241 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual Treatment (IT)
Number of subjects: 113
Study 7924241 — intervention group
Group type: COMPARATOR
Intervention: Static Control Group
Number of subjects: 113
Study 7924241 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual Treatment (Rehearsal IT)
Number of subjects: 113
Study 2573963 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucralfate
Number of subjects: 142
Study 2573963 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine
Number of subjects: 142
Study 2573963 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 142
Study 2573963 — intervention group
Group type: EXPERIMENTAL
Intervention: Antacids and cholinolytics
Number of subjects: 142
Study 4840431 — intervention group
Group type: EXPERIMENTAL
Intervention: Buffered cephalothin solution
Number of subjects: 13
Study 4840431 — intervention group
Group type: COMPARATOR
Intervention: Unbuffered cephalothin solution
Number of subjects: 13
Study 31167050 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (twice yearly for 2 years, followed by additional distributions in MORDOR II)
Number of subjects: 594
Study 31167050 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (additional distributions in MORDOR II)
Number of subjects: 594
Study 31167050 — intervention group
Group type: COMPARATOR
Intervention: Placebo (first 2 years in MORDOR I)
Number of subjects: 594
Study 31167050 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (continued for an additional year)
Number of subjects: 594
Study 28571671 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifidobacterium breve strain BBG‐001 (probiotic)
Number of subjects: 103
Study 28571671 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103
Study 28571671 — intervention group
Group type: EXPERIMENTAL
Intervention: Early antibiotic exposure
Number of subjects: 103
Study 26028347 — intervention group
Group type: EXPERIMENTAL
Intervention: HELP-COPD
Number of subjects: 32
Study 26028347 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 32
Study 24004465 — intervention group
Group type: EXPERIMENTAL
Intervention: PCV13
Number of subjects: 619
Study 24004465 — intervention group
Group type: COMPARATOR
Intervention: PCV7
Number of subjects: 619
Study 22068177 — intervention group
Group type: EXPERIMENTAL
Intervention: P5: alkaline hypochlorite for 10 minutes
Number of subjects: 15
Study 22068177 — intervention group
Group type: EXPERIMENTAL
Intervention: P6: home use chlorine solution (Q'boa® at 0.45% for 10 min)
Number of subjects: 15
Study 22068177 — intervention group
Group type: EXPERIMENTAL
Intervention: P4: brushing with water and liquid soap for 40 s
Number of subjects: 15
Study 22068177 — intervention group
Group type: EXPERIMENTAL
Intervention: P3: cleaning with alkaline peroxide (Corega Tabs®) for 30 min
Number of subjects: 15
Study 22068177 — intervention group
Group type: EXPERIMENTAL
Intervention: P2: cleaning with alkaline peroxide (Corega Tabs®) for 5 min
Number of subjects: 15
Study 22068177 — intervention group
Group type: EXPERIMENTAL
Intervention: P1: washing under running water for 20 s
Number of subjects: 15
Study 19816370 — intervention group
Group type: EXPERIMENTAL
Intervention: Bottle-feeding with the usual nipple (G1, N = 42)
Number of subjects: 82
Study 19816370 — intervention group
Group type: COMPARATOR
Intervention: Feeding with a spoon, cup, or syringe (G2, N = 40)
Number of subjects: 82
Study 19816370 — intervention group
Group type: EXPERIMENTAL
Intervention: Bottle-feeding (G1)
Number of subjects: 82
Study 19816370 — intervention group
Group type: COMPARATOR
Intervention: Feeding with a spoon, cup, or syringe (G2)
Number of subjects: 82
Study 19816370 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (G1 and G2)
Number of subjects: 82
Study 17013635 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (capsules containing an amino acid mixture specifically lacking tryptophan)
Number of subjects: 0
Study 17013635 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsules containing lactose
Number of subjects: 0
Study 12723103 — intervention group
Group type: EXPERIMENTAL
Intervention: Float-Brush
Number of subjects: 42
Study 12723103 — intervention group
Group type: COMPARATOR
Intervention: Techno-Brush
Number of subjects: 42
Study 12723103 — intervention group
Group type: COMPARATOR
Intervention: Manual toothbrush
Number of subjects: 42
Study 11045790 — intervention group
Group type: EXPERIMENTAL
Intervention: fenretinide (200 mg day p.o. for 24 months)
Number of subjects: 99
Study 11045790 — intervention group
Group type: COMPARATOR
Intervention: no intervention (control)
Number of subjects: 99
Study 9253394 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenoidectomy
Number of subjects: 0
Study 9253394 — intervention group
Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 0
Study 8487136 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA (topical anesthetic)
Number of subjects: 73
Study 30971236 — intervention group
Group type: EXPERIMENTAL
Intervention: Further Enabling Care at Home (FECH) program
Number of subjects: 21
Study 28532509 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized dialysis temperature (IDT) of 0.5 °C below body temperature
Number of subjects: 18